Clayton Harro

3.6k total citations
42 papers, 2.5k citations indexed

About

Clayton Harro is a scholar working on Infectious Diseases, Immunology and Endocrinology. According to data from OpenAlex, Clayton Harro has authored 42 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 16 papers in Immunology and 14 papers in Endocrinology. Recurrent topics in Clayton Harro's work include Viral gastroenteritis research and epidemiology (16 papers), Escherichia coli research studies (14 papers) and Immunotherapy and Immune Responses (12 papers). Clayton Harro is often cited by papers focused on Viral gastroenteritis research and epidemiology (16 papers), Escherichia coli research studies (14 papers) and Immunotherapy and Immune Responses (12 papers). Clayton Harro collaborates with scholars based in United States, United Kingdom and Canada. Clayton Harro's co-authors include Allan Hildesheim, John T. Schiller, David A. Sack, Lígia A. Pinto, Subhra Chakraborty, A. Louis Bourgeois, Barbara DeNearing, Richard B.S. Roden, Richard I. Walker and Ruth A. Karron and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Journal of Immunology.

In The Last Decade

Clayton Harro

42 papers receiving 2.4k citations

Peers

Clayton Harro
Ralf Ignatius Germany
Jan Weel Netherlands
Julie K. Pfeiffer United States
Tatiane A. Paíxão Brazil
Michael Vajdy United States
Jolanta Kurz Canada
F. Schödel United States
Audino Podda Italy
William C. Weldon United States
Yoshinobu Okuno Japan
Ralf Ignatius Germany
Clayton Harro
Citations per year, relative to Clayton Harro Clayton Harro (= 1×) peers Ralf Ignatius

Countries citing papers authored by Clayton Harro

Since Specialization
Citations

This map shows the geographic impact of Clayton Harro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clayton Harro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clayton Harro more than expected).

Fields of papers citing papers by Clayton Harro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clayton Harro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clayton Harro. The network helps show where Clayton Harro may publish in the future.

Co-authorship network of co-authors of Clayton Harro

This figure shows the co-authorship network connecting the top 25 collaborators of Clayton Harro. A scholar is included among the top collaborators of Clayton Harro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clayton Harro. Clayton Harro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sheikh, Alaullah, Tim J. Vickers, Bernhard B. Singer, et al.. (2024). Host-derived CEACAM-laden vesicles engage enterotoxigenic Escherichia coli for elimination and toxin neutralization. Proceedings of the National Academy of Sciences. 121(38). e2410679121–e2410679121. 1 indexed citations
2.
3.
4.
Chakraborty, Subhra, Arlo Randall, Tim J. Vickers, et al.. (2019). Interrogation of a live-attenuated enterotoxigenic Escherichia coli vaccine highlights features unique to wild-type infection. npj Vaccines. 4(1). 37–37. 26 indexed citations
5.
Harro, Clayton, A. Louis Bourgeois, David A. Sack, et al.. (2019). Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge. Vaccine. 37(14). 1978–1986. 59 indexed citations
6.
Pop, Mihai, Joseph N. Paulson, Subhra Chakraborty, et al.. (2016). Individual-specific changes in the human gut microbiota after challenge with enterotoxigenic Escherichia coli and subsequent ciprofloxacin treatment. BMC Genomics. 17(1). 440–440. 51 indexed citations
7.
Porter, Chad K., Mark S. Riddle, David A. Sack, et al.. (2016). An Evidenced-Based Scale of Disease Severity following Human Challenge with Enteroxigenic Escherichia coli. PLoS ONE. 11(3). e0149358–e0149358. 30 indexed citations
8.
Yang, William, Sunil Suchindran, Bradly P. Nicholson, et al.. (2016). Transcriptomic Analysis of the Host Response and Innate Resilience to EnterotoxigenicEscherichia coliInfection in Humans. The Journal of Infectious Diseases. 213(9). 1495–1504. 10 indexed citations
9.
Harro, Clayton, Robert F. Betts, Jonathan Hartzel, et al.. (2011). The immunogenicity and safety of different formulations of a novel Staphylococcus aureus vaccine (V710): Results of two Phase I studies. Vaccine. 30(9). 1729–1736. 46 indexed citations
10.
Atmar, Robert L., David I. Bernstein, Clayton Harro, et al.. (2011). Norovirus Vaccine against Experimental Human Norwalk Virus Illness. New England Journal of Medicine. 365(23). 2178–2187. 363 indexed citations
11.
12.
Garcı́a-Piñeres, Alfonso, Allan Hildesheim, Lori E. Dodd, et al.. (2009). Gene Expression Patterns Induced by HPV-16 L1 Virus-Like Particles in Leukocytes from Vaccine Recipients. The Journal of Immunology. 182(3). 1706–1729. 21 indexed citations
13.
Harro, Clayton, Michael Robertson, Michelle Lally, et al.. (2008). Safety and Immunogenicity of Adenovirus-Vectored Near-Consensus HIV Type 1 Clade B gag Vaccines in Healthy Adults. AIDS Research and Human Retroviruses. 25(1). 103–114. 46 indexed citations
14.
Russell, Nina D., Barney S. Graham, Michael C. Keefer, et al.. (2006). Phase 2 Study of an HIV-1 Canarypox Vaccine (vCP1452) Alone and in Combination With rgp120. JAIDS Journal of Acquired Immune Deficiency Syndromes. 44(2). 203–212. 69 indexed citations
15.
Okazaki, Takahiro, C D Pendleton, Pablo Sarobe, et al.. (2006). Epitope Enhancement of a CD4 HIV Epitope toward the Development of the Next Generation HIV Vaccine. The Journal of Immunology. 176(6). 3753–3759. 10 indexed citations
16.
Goepfert, Paul A., Georgia D. Tomaras, Helen Horton, et al.. (2006). Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers. Vaccine. 25(3). 510–518. 71 indexed citations
17.
Gurwith, Marc, D. P. Francis, Clayton Harro, et al.. (2003). Differential efficacy in prevention of HIV infection by rgp120 HIV-1 vaccine by gender and race Is it real?. 43. 334. 1 indexed citations
18.
Kim, Myong‐Jin, Anne N. Nafziger, Clayton Harro, et al.. (2003). Revaccination of healthy nonresponders with hepatitis B vaccine and prediction of seroprotection response. Vaccine. 21(11-12). 1174–1179. 42 indexed citations
19.
Harro, Clayton, Yi Pang, Richard B.S. Roden, et al.. (2001). Safety and Immunogenicity Trial in Adult Volunteers of a Human Papillomavirus 16 L1 Virus-Like Particle Vaccine. JNCI Journal of the National Cancer Institute. 93(4). 284–292. 454 indexed citations
20.
Harro, Clayton, et al.. (1997). Failure to Cure Mycobacterium gordonae Peritonitis Associated with Continuous Ambulatory Peritoneal Dialysis. Clinical Infectious Diseases. 24(5). 955–957. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ralf Ignatius Breakdown of academic impact, for papers by Jan Weel Breakdown of academic impact, for papers by Julie K. Pfeiffer Breakdown of academic impact, for papers by Tatiane A. Paíxão Breakdown of academic impact, for papers by Michael Vajdy Breakdown of academic impact, for papers by Jolanta Kurz Breakdown of academic impact, for papers by F. Schödel Breakdown of academic impact, for papers by Audino Podda Breakdown of academic impact, for papers by William C. Weldon Breakdown of academic impact, for papers by Yoshinobu Okuno
Rankless by CCL
2026